Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratumoral Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05132803
What this trial is testing

TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers

Who this might be right for
Recurrent Human Papillomavirus Type 16 Associated Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT02045589
What this trial is testing

A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
Theriva Biologics SL 8
Early research (Phase 1)WithdrawnNCT07100925
What this trial is testing

Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Renal TransplantSolid Tumor+1 more
Ankyra Therapeutics, Inc
Testing effectiveness (Phase 2)Study completedNCT00499083
What this trial is testing

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Who this might be right for
Breast Cancer
University of Nebraska 17
Early research (Phase 1)Ended earlyNCT01745354
What this trial is testing

Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
Robert Lowsky 6
Early research (Phase 1)UnknownNCT03638765
What this trial is testing

Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer

Who this might be right for
Brain MetastasesLung Cancer MetastaticBreast Cancer Metastatic
Northwest Biotherapeutics 24
Early research (Phase 1)Ended earlyNCT04144140
What this trial is testing

Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101

Who this might be right for
LymphomaAdvanced Solid Tumors
Eisai Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04673942
What this trial is testing

AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultCancerNeoplasms+3 more
EpicentRx, Inc. 140
Early research (Phase 1)Ended earlyNCT06182579
What this trial is testing

Phase I Study of RiMO-401 With Radiation in Advanced Tumors

Who this might be right for
Advanced Solid TumorIntratumoral Injection
Coordination Pharmaceuticals, Inc. 5
Early research (Phase 1)Study completedNCT04059588
What this trial is testing

A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin

Who this might be right for
CancerSolid TumorCancer of Skin
Rockefeller University 16
Very early researchStudy completedNCT06366451
What this trial is testing

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Presage Biosciences 17
Testing effectiveness (Phase 2)Temporarily pausedNCT05756556
What this trial is testing

T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

Who this might be right for
MelanomaMalignant Melanoma
ImmVira Pharma Co. Ltd 68
Testing effectiveness (Phase 2)Study completedNCT03993678
What this trial is testing

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Swiss Cancer Institute 28
Testing effectiveness (Phase 2)WithdrawnNCT04044950
What this trial is testing

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Who this might be right for
Papillomavirus InfectionsOropharyngeal Neoplasms
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT03088176
What this trial is testing

Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma

Who this might be right for
MelanomaBRAF Gene Mutation
West Cancer Center 4
Early research (Phase 1)Looking for participantsNCT06171750
What this trial is testing

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more
Ankyra Therapeutics, Inc 97
Testing effectiveness (Phase 2)Ended earlyNCT02266147
What this trial is testing

Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Dynavax Technologies Corporation 29
Testing effectiveness (Phase 2)Study completedNCT00496236
What this trial is testing

Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Neoplasms
GenVec
Testing effectiveness (Phase 2)UnknownNCT01882946
What this trial is testing

Safety and Efficacy Study of DCVax-Direct in Solid Tumors

Who this might be right for
Locally Advanced TumorMetastatic Solid Tissue TumorsLiver Cancer+3 more
Northwest Biotherapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT06249048
What this trial is testing

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 108
Next Page